Recruiting NA Dementia Prevention

New treatment option for Dementia Prevention

Official title The Brain Health PRO Online Risk Factor Reduction Study to Prevent Dementia

ClinicalTrials.gov ID: NCT07364019

What this study is testing

What it's testing
This study will recruit participants at risk for dementia to participate in an online educational program called Brain Health PRO (BHPro). The BHPro intervention is designed to address modifiable risk factors for dementia through a 6-month, fully online, educational program conveying the best available evidence for lifestyle changes that can mitigate dementia risk, and foster engagement toward one's own brain health.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 50 to 80. Healthy volunteers may be eligible.

You may be able to join if

  • Completion and documentation of the electronic Informed Consent Process (from the participant)
  • Sufficient proficiency in English or French to undergo online assessments and participate in an online educational program.
  • Technical ability to participate in an online educational program and remote assessments (i.e., regularly have access to a computer or tablet with an...
  • Sufficient vision to participate in an online educational program and complete online cognitive testing
  • Ages 50-80

You likely can't join if

  • Individuals who have a clinical diagnosis of Dementia (based on self-report)
  • Individuals who are currently participating in or have participated in a past study involving BHPro
See the full eligibility criteria
Who can join
  • Completion and documentation of the electronic Informed Consent Process (from the participant)
  • Sufficient proficiency in English or French to undergo online assessments and participate in an online educational program.
  • Technical ability to participate in an online educational program and remote assessments (i.e., regularly have access to a computer or tablet with an internet connection; have access to a desktop or laptop computer with...
  • Sufficient vision to participate in an online educational program and complete online cognitive testing
  • Ages 50-80
  • Classified as being at increased risk of dementia based on at least one of the following:
  • First-degree family history of dementia
  • Education level at or below high school (grade 12 or less)
  • Self-Reported: Hypertension, Hypercholesterolemia, Body Mass Index \> 30 kg/m2 (derived from NIH Metric BMI Calculator), or Physical Inactivity (active is defined as engaging in a minimum of 20- 30 min of physical...
What rules you out
  • Individuals who have a clinical diagnosis of Dementia (based on self-report)
  • Individuals who are currently participating in or have participated in a past study involving BHPro

The study team makes the final eligibility decision.

Where it's taking place

  • Vancouver, British Columbia, Canada

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 50 years to 80 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Vancouver, British Columbia, Canada. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.